securities class action

$EOSE plummeted 39% after revealing 25% FY2025 revenue shortfall and production problems. Securities lawsuit alleges management concealed scaling issues from investors.

Trip.com shares crater 17% amid Chinese anti-monopoly investigation into allegedly coercive AI pricing tool. Securities class action filed; tool shut down, co-founders resign.

Rosen Law Firm seeks lead plaintiffs in securities class action against Corcept Therapeutics, alleging misrepresentation of FDA communications and clinical trial data for relacorilant drug.

Rosen Law Firm files securities class action against REGENXBIO for alleged false statements on product safety and efficacy, with April 14, 2026 lead plaintiff deadline.

Law firm Kirby McInerney pursues class action against $NAVN over alleged IPO disclosure failures. Stock fell 11.89% after disappointing earnings revealed $225M loss.

Lakeland Industries investors have until April 24, 2026 to join securities class action alleging overstatement of Pacific Helmets and Jolly businesses while concealing shipping delays, production issues, and tariff pressures. Stock fell 39% after guidance withdrawal and CFO termination.

ODDITY Tech ($ODD) shares crashed 49% after disclosing 30% Q1 revenue decline tied to advertising partner algorithm change. Securities class action filed.

CRMT shares fell 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year, prompting securities investigation.

PennyMac Financial Services stock crashed 33% following Q4 2025 earnings miss, triggering securities investigation and class action lawsuit preparation by Rosen Law Firm.

Rosen Law Firm urges Navan IPO investors to join securities class action by April 24, 2026 deadline, alleging false/misleading IPO disclosures regarding sales and marketing expenses.

Hub Group disclosed accounting errors requiring restatement of Q1-Q3 2025 financials, triggering 18.3% stock decline. Law firm investigates shareholder claims.

Securities lawsuit filed against $BRBR over alleged misleading statements on sales growth and competitive positioning. Stock declined after corrective disclosures; lead plaintiff applications due March 23, 2026.

Securities class action filed against $RARE for allegedly misrepresenting setrusumab efficacy data. Investors may claim damages; lead plaintiff deadline April 6, 2026.

Rosen Law Firm files securities class action against Inovio Pharmaceuticals ($INO) alleging misleading statements on manufacturing deficiencies and overstated regulatory prospects. Lead plaintiff deadline April 7, 2026.

Rosen Law Firm urges PomDoctor Ltd. investors to join securities class action before April 7, 2026 deadline. Allegations include false statements, insider dumping, and artificial trading schemes.

Rosen Law Firm alerts $METC investors of securities class action lawsuit alleging false statements about mining operations. Class certification deadline set for March 31, 2026.

Rosen Law Firm urges Apollo Global Management investors to join securities class action alleging executives made false statements about Jeffrey Epstein business dealings.

PayPal faces securities class action lawsuit alleging misleading statements about 2027 financial targets and Branded Checkout growth potential. Eligible shareholders have until April 20, 2026 deadline to secure counsel.

Securities class action filed against $BRBR alleging false representation of sales growth. Lead plaintiff deadline: March 23, 2026.

Snowflake faces securities class action alleging failure to disclose how product efficiency improvements would materially harm consumption-based revenue model.